HONG KONG, Sept. 29, 2025 -- Since 2025, the medical and healthcare sector have become a hot investment target in Hong Kong capital market. According to the Hang Seng Index Company, the healthcare industry has surged by as much as 91.2% from the beginning of the year until late August, making it the best-performing sector among the 12 industry indices of the Hang Seng Composite Index. Among healthcare-related stocks, Home Control(1747.HK) has shown strong growth potential following its expansion from smart home IoT to home medical fields, backed by its solid background of experiences in European and American markets. Recently, there were addition of several new directors in Home Control, who have extensive industry experience and network, including connections with a Singaporean medical enterprise and a conglomerate from Indonesia.
The management team of Home Control comes from Phillips, a famous Dutch multinational electronics company, which has been providing smart home IoT products and services to international markets for years. Recently, Home Control has been expanding into the healthcare field, revealing a strong international board. The new directors have connection with one major Singaporean medical enterprise and the second largest multinational conglomerate company in Indonesia. Firstly, the newly appointed non-executive director, Ms. Ma Ying, was a founding member and the Chairman and Legal Representative of the "Zhejiang Jack Ma Public Welfare Foundation" established in 2014. Holding the rank of Research Librarian (equivalent to a professorial level) and an investor, Ms. Ma has accumulated extensive experience in the fields of digital healthcare and smart health services, while also establishing a broad network in the public welfare and education sectors. Notably, her connections with leading figures in China's new economy and related ecosystems provide the company with greater strategic opportunities in the integration of fintech and healthcare industries.
In addition, another newly appointed independent non-executive director, Mr. Chen Yi Chung, also with background in healthcare sector, currently serves as the Chief Operating Officer of OUE Limited, a Singapore-listed healthcare and real estate group which was invested by Lippo Limited. The Chairman of Lippo Limited, Dr Stephen Riady is also the Chief Executive Officer of OUE Limited. And Lippo Limited is under Lippo Group, the second largest conglomerate in Indonesia with substantial financial strength and network resources. OUE Limited's healthcare business spans Singapore, China, Myanmar, Indonesia, and Japan, operating over 130 clinics and medical centers in Singapore, and it has established an international medical centre in Shenzhen in partnership with the Chinese University of Hong Kong.
Hong Kong subsidiary Orbiva Limited integrating hardware, software, data and services, cultivating innovative technologies such as AI and Web3
With the massive medical resources and network support, Home Control has recently initiated its strategic layout in the healthcare field by establishing Orbiva Limited, a wholly-owned subsidiary in Hong Kong to build an AIoT-enabled home healthcare platform and ecosystem, providing healthcare operation services, integrating hardware, software, data and services. Home Control is also incubating smart connected health hardware for the homecare scene, such as wearable monitoring devices, intelligent interactive products, integrated control terminals, etc. It will also cultivate innovative technologies that can be strategically integrated into its development plans, such as AI and Web3 technologies, to enrich the platform's capabilities and expand innovative applications, ultimately building a people-centric health service ecosystem.
The company has significant growth potential, contributing approximately 20% to the healthcare sector in the first half of 2025. In the future, as it integrates innovative technologies such as AI and Web3 to create an all-in-one health management platform, it will continue to attract investment.
